Additional information
| Strength | 0.25MG, 0.5MG, 1 MG, 1.7MG, 2.4MG, 7.2MG |
|---|---|
| Quantity | 1 MONTH SUPPLY, 2 MONTH SUPPLY, 3 MONTH SUPPLY |
Wegovy is a GLP-1-based prescription medicine containing semaglutide as the main ingredient. It is a once-weekly injection to help people struggling with obesity lose weight under medical supervision. P.s. Wegovy 7.2mg is NOW AVAILABLE
£99.99 – £749.99Price range: £99.99 through £749.99
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
| Strength | 0.25MG, 0.5MG, 1 MG, 1.7MG, 2.4MG, 7.2MG |
|---|---|
| Quantity | 1 MONTH SUPPLY, 2 MONTH SUPPLY, 3 MONTH SUPPLY |
Wegovy is a prescription-only, GLP-1 receptor weight loss medication containing Semaglutide as the main ingredient. Injected once weekly, it has shown an average of 21% weight loss over 72 weeks when combined with lifestyle changes.
Wegovy is designed to support long-term weight management rather than short-term weight loss. It is typically prescribed for people who have found it difficult to lose weight through diet and exercise alone, particularly where excess weight is affecting overall health or increasing the risk of future health conditions.
For many patients, the biggest benefit of Wegovy is that it can make it easier to follow a calorie-controlled plan by reducing appetite, supporting portion control, and lowering cravings over time.
GLP-1 is a naturally occurring hormone responsible for regulating appetite and helping you stay full for a long time. Wegovy mimics the action of GLP-1 and helps your body stay satiated by controlling appetite and reducing cravings.
Studies have shown that eating habits become easier to control when combined with sustained physical activity. Wegovy is effective because it directly acts on appetite pathways, so patients don’t have to rely on willpower alone.
Over time, this change in appetite helps create a sustained calorie deficit—crucial for meaningful weight loss. Step by step, people build consistent routines around food, activity, and sleep—the pillars of long-term weight management.
Wegovy is intended for adults who meet the following criteria:
You can buy Wegovy online through The Care Pharmacy with a simple consultation to confirm your suitability. We’ll review your medical history, current medications, and assess any risks to ensure treatment is safe and effective.
Eligibility is not based on BMI alone. A clinician will also consider your overall health, medical history, and whether Wegovy is likely to be safe and suitable for you. This is particularly important if you have other conditions or take regular medication.
Wegovy is not suitable for everyone, and a full medical assessment is required before starting treatment.
You may not be eligible if you:
In some cases, Wegovy may not be suitable, including during pregnancy or breastfeeding, or for people with certain medical conditions. This is why an honest consultation and safety screening is always essential before starting treatment. A regulated UK pharmacy will review your medical history, current medications, and overall health to ensure Wegovy is safe and appropriate for you.
Wegovy is administered once weekly using a pre-filled pen. The starting dose is 0.25 mg and is gradually increased every four weeks based on your body’s response. This slow titration helps minimise side effects.
Dosage goes up incrementally:
In the first few weeks, many people feel full sooner during meals and are less tempted by large portions or late-night snacks. To get the best results, we recommend:
Wegovy is now available in a higher 7.2 mg weekly maintenance dose — the strongest licensed dose of semaglutide in the UK following MHRA approval in January 2026. It can be prescribed at The Care Pharmacy following a clinical consultation to confirm it is right for you.
In clinical trials, the 7.2 mg dose helped patients lose an average of around 20.7% of their body weight over 72 weeks, compared with around 17.5% on the standard 2.4 mg dose. This brings semaglutide’s results closer to those seen with Mounjaro (tirzepatide).
| Feature | Wegovy 7.2 mg | Mounjaro 15 mg |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| How it works | GLP-1 receptor agonist | Dual GIP and GLP-1 receptor agonist |
| Highest weekly maintenance dose | 7.2 mg | 15 mg |
| How it’s taken | Once-weekly injection | Once-weekly injection |
| Average weight loss in trials | Around 20.7% over 72 weeks (STEP UP trial) | Around 20.9–22.5% over 72 weeks (SURMOUNT-1 trial) |
| UK status | Licensed; MHRA-approved higher dose (January 2026) | Licensed for weight management |
These figures come from separate clinical trials and are not a direct head-to-head comparison. Average results are a guide only — individual weight loss varies depending on starting weight, dose, lifestyle changes, and how consistently treatment is followed. Our clinical team will help you decide which treatment is most suitable for you.
Wegovy prices generally increase with the dose. Lower doses are typically more affordable, but they are only used for a short adjustment period.
Most people remain on the 2.4mg weekly injection for long-term use, and that’s where the true cost is reflected.
That’s why The Care Pharmacy offers some of the most affordable prices for Wegovy in the UK, without hidden fees. Whether you’re starting out or on the maintenance dose, we provide competitive pricing across all strengths.
| Wegovy Dose | 1 Pen (4 Doses) | 2 Pens (8 Doses) | 3 Pens (12 Doses) |
|---|---|---|---|
| 0.25mg | £99.99 | £199.98 | £279.99 |
| 0.5mg | £129.99 | £259.98 | £389.97 |
| 1mg | £129.99 | £259.98 | £389.97 |
| 1.7mg | £179.99 | £359.98 | £539.97 |
| 2.4mg | £229.99 | £459.98 | £689.97 |
| 7.2mg | £249.99 | £499.99 | £749.99 |
Clinical trials have shown that patients taking Wegovy (semaglutide) at the maintenance dose of 2.4mg lost an average of 15% to 21% of their body weight over 68 weeks when combined with diet and exercise. Results vary depending on your starting weight, lifestyle, and how consistently you follow your treatment plan.
Use the calculator below to get a personalised estimate of your potential weight loss on Wegovy. It can help you set realistic goals before starting treatment with The Care Pharmacy.
These estimates are based on published clinical trial data and should be used as a guide only. Individual results depend on factors including starting weight, dose, lifestyle changes, and adherence to treatment. A consultation with our clinical team will help determine whether Wegovy is the right option for you.
Wegovy comes as a pre-filled injection pen that you use once a week. It is only for your personal use and should never be shared with anyone else.
Wegovy is injected just under the skin (subcutaneous injection).
Most side effects of Wegovy are mild to moderate, especially at the beginning of treatment, and tend to improve as your body adjusts. Because Wegovy works on the digestive system, many of the most common effects are related to the stomach and bowels.
These are the most frequently reported and usually settle with time:
While rare, some patients may experience more serious reactions that need medical attention:
If you use Wegovy alongside medicines for diabetes (particularly insulin or sulfonylureas), your risk of low blood sugar may increase. Symptoms include sweating, shakiness, fast heartbeat, hunger, or confusion. If you experience any of these, seek medical attention immediately.
Stop using Wegovy and get medical help right away if you develop:
It is always best to read the patient information leaflet inside your pack to be aware of potential side effects before starting.
Wegovy is a prescription-only medicine and may not be suitable for everyone. Before starting treatment, we require patients to complete a consultation to assess your health history and ensure this medicine is safe for you.
It is important to use Wegovy exactly as prescribed and to follow the recommended dose increases. Starting too high or increasing too quickly can raise the risk of side effects, particularly nausea and stomach upset. Most patients do best when they take the injection on the same day each week, maintain regular meals, and stay well hydrated throughout treatment.
You should also be aware that Wegovy is intended to support long-term weight management. It works best when used alongside lifestyle changes such as a calorie-controlled diet, increased physical activity, and improved sleep routines. While many patients experience appetite reduction, it is still important to eat balanced meals and avoid skipping food completely, as this can increase fatigue and worsen side effects.
You should not use Wegovy if you:
Extra care is needed if you:
It is also worth noting that Wegovy can slow digestion. For some people, this may worsen existing digestive symptoms or contribute to side effects such as constipation, bloating, or reflux. Eating smaller meals, avoiding very rich foods, and drinking enough water can often help reduce these effects, particularly during dose increases.
During treatment, seek urgent medical advice if you develop severe stomach pain, signs of gallbladder problems, or symptoms of an allergic reaction such as swelling of the face, lips, or throat.
You should also seek advice promptly if you experience ongoing vomiting or diarrhoea, as this can lead to dehydration and may affect kidney function in some patients. If you are struggling to keep fluids down or feel unusually weak, it is important to get checked quickly.
Always read the patient information leaflet provided in your pack for the full list of warnings, precautions, and advice.
Wegovy contains the active medicine semaglutide, which is a GLP-1 receptor agonist. This is the ingredient that helps control appetite, reduce cravings, and support long-term weight loss.
Alongside the active medicine, Wegovy also contains several inactive ingredients. These are added to stabilise the injection solution, keep the medicine safe during storage, and ensure it can be delivered effectively under the skin.
It is important to note that Wegovy does not contain preservatives, lactose, or gluten.
Patients with known allergies to any of the ingredients should not use this medicine or should discuss it with the prescriber.



Reviews
There are no reviews yet.